Cardiol Therapeutics Inc Class A is facing notable pressure in the market, with shares down nearly 4%.
Cardiol Therapeutics Inc Class A (CRDL.TO) is having a tough trading day, with its stock price dropping by 3.79% to close at CA$2.03. This decline reflects ongoing investor concerns and market dynamics that are affecting its performance.
Advertisement
Cardiol Therapeutics Inc Class A
CRDL.TO
CRDL.TO
Cardiol Therapeutics Inc Class A
WealthAwesomeAdvertisement
Market cap
$237.46M
52W high
$2.33
52W low
$1.23
1W change
+9.90%
Beta
0.47
Analyst Price Targets
Based on analyst covering CRDL
Wall Street analysts forecast CRDL stock price to rise 184.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+184.4% Upside
Current Price
C$2.11
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRDL's historical volatility
30-Day Vol
60.9%
Annualized
90-Day Vol
56.0%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$2.52
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$2.24 | C$1.82 – C$2.76 |
| 60 trading days | C$2.38 | C$1.77 – C$3.20 |
| 90 trading days | C$2.52 | C$1.75 – C$3.63 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should keep an eye on Cardiol's developments and market sentiment, as today’s drop may signal underlying issues that could impact future performance.
3.79% Drop
Cardiol's stock has decreased by 3.79% in today’s trading session, reflecting investor caution.
Bull case
If Cardiol can effectively use its recent clinical data and expand its trial networks, there’s potential for recovery and a boost in investor confidence.
Bear case
Ongoing weakness in the share price might indicate deeper issues within the company or sector, which could lead to further declines if not addressed.
Advertisement
Market Performance Overview
Cardiol Therapeutics Inc Class A's stock price has decreased by 3.79% today, raising concerns among investors. With a market cap of CA$237.46 million, the company is under scrutiny as it navigates a competitive landscape in the biotech sector.
Investor Sentiment and Future Outlook
The recent drop in stock price may reflect investor worries about Cardiol's future prospects. Despite previous announcements, like the publication of Phase II data, the market reaction suggests that stakeholders are cautious about the company's ability to capitalize on its advancements. Investors should watch for upcoming developments and market reactions to assess potential recovery.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
